Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

OGALLALA COMMUNITY HOSPITAL

NPI: 1710915467 · OGALLALA, NE 69153 · Critical Access Hospital · NPI assigned 06/30/2006

$1.20M
Total Medicaid Paid
19,564
Total Claims
15,317
Beneficiaries
43
Codes Billed
2018-01
First Month
2024-06
Last Month

Provider Details

Authorized OfficialGULLINGSRUD, TIMOTHY (CEO)
Parent OrganizationBANNER HEALTH
NPI Enumeration Date06/30/2006

Related Entities

Other providers sharing the same authorized official: GULLINGSRUD, TIMOTHY

ProviderCityStateTotal Paid
OGALLALA COMMUNITY HOSPITAL OGALLALA NE $515K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 3,725 $165K
2019 3,774 $215K
2020 2,393 $167K
2021 4,227 $241K
2022 4,122 $318K
2023 1,137 $81K
2024 186 $9K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 1,333 1,015 $269K
99283 Emergency department visit for the evaluation and management, moderate severity 1,359 1,145 $230K
80053 Comprehensive metabolic panel 2,998 2,476 $146K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2,072 1,734 $129K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2,961 2,429 $66K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 139 109 $49K
84443 Thyroid stimulating hormone (TSH) 1,132 932 $45K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 660 604 $40K
99282 Emergency department visit for the evaluation and management, low to moderate severity 288 261 $35K
J3490 Unclassified drugs 1,496 689 $28K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 415 366 $27K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 669 337 $26K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 281 120 $17K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 105 26 $9K
87631 54 53 $9K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 94 86 $8K
83036 Hemoglobin; glycosylated (A1C) 343 330 $8K
36415 Collection of venous blood by venipuncture 1,323 1,102 $7K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 128 125 $6K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 83 24 $6K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 98 92 $5K
80061 Lipid panel 129 123 $4K
81001 244 213 $4K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 113 92 $4K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 38 32 $3K
87086 Culture, bacterial; quantitative colony count, urine 84 77 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 86 76 $2K
86140 72 66 $2K
85027 66 61 $1K
80048 Basic metabolic panel (calcium, ionized) 39 37 $1K
J8499 Prescription drug, oral, non chemotherapeutic, nos 359 220 $1K
96375 Therapeutic injection; each additional sequential IV push 15 12 $1K
71045 Radiologic examination, chest; single view 16 13 $868.57
81003 102 96 $864.77
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 12 12 $750.42
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 16 16 $630.92
J1885 Injection, ketorolac tromethamine, per 15 mg 33 30 $598.03
85610 30 24 $394.85
97530 Therapeutic activities, direct patient contact, each 15 minutes 17 12 $292.12
A9270 Non-covered item or service 15 12 $290.23
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 16 12 $267.50
82043 15 14 $176.32
J7030 Infusion, normal saline solution , 1000 cc 16 12 $76.31